Inhibition of cGMP-Phosphodiesterase-5 By Biflavones of Ginkgo biloba

Abstract

Ginkgo biloba dimeric flavonoids (GBDF) were shown to inhibit cAMP phosphodiesterase activity and to promote vasorelaxation. In particular, amentoflavone exhibited endothelium-dependent relaxation of rat aorta rings via enhanced generation and/or increased biological activity of nitric oxide, leading to elevated cGMP levels. The aim of this study was to investigate whether GBDF were able to inhibit cGMP-specific phosphodiesterase-5 (PDE5) as well. Human recombinant PDE5A1 was prepared by expression of the full-length cDNA of PDE5A1 in COS-7 cells. The PDE activity was determined in the presence of biflavones at 0.1 - 100 μM. All biflavones inhibited PDE5A1 in a concentration-dependent fashion, ginkgetin being the most potent (IC₅₀ = 0.59 μM). The ability to inhibit the enzyme followed this order: ginkgetin > bilobetin > sciadopitysin > amentoflavone > sequoiaflavone. These data suggest that GBDF could exert a vasodilating effect through a mechanism independent of NO release.

References

• 1 Vesper J, Hansegen K. Efficacy of Ginkgo biloba in 90 outpatients with cerebral insufficiency caused by old age; results of a placebo-controlled double-blind trial. Phytomedicine 1994: 9-16
• 2 Auguet M, De Feudis F V, Clostre F. Effects of Ginkgo biloba on arterial smooth muscle responses to vasoactive stimuli.  Gen Pharmacol. 1982;  13 169-71
• 3 Paick J S, Lee J H. An experimental study of the effect of Ginkgo biloba extract on the human and rabbit corpus cavernosum tissue.  J Urol. 1996;  156 1876-80
• 4 Bombardelli E, Cristoni A, Curri S. Activity of phospholipid-complex of Ginkgo biloba dimeric flavonoids on the skin microcirculation.  Fitoterapia. 1996;  67 265-73
• 5 Kang D G, Yin M H, Oh H, Lee D H, Lee H S. Vasorelaxation by amentoflavone isolated from Selaginella tamariscina .  Planta Med. 2004;  70 718-22
• 6 Rybalkin S D, Rybalkina I G, Feil R, Hofmann F, Beavo J A. Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells.  J Biol Chem. 2002;  277 3310-7
• 7 Pauvert O, Lugnier C, Keravis T, Marthan R, Rousseau E, Savineau J P. Effect of sildenafil on cyclic nucleotide phosphodiesterase activity, vascular tone and calcium signaling in rat pulmonary artery.  Br J Pharmacol. 2003;  139 513-22
• 8 Corbin J D. Mechanisms of action of PDE5 inhibition in erectile dysfunction.  Int J Impot Res. 2004;  16 (Suppl 1) S4-7
• 9 Koyama H, Bornfeldt K E, Fukumoto S, Nishizawa Y. Molecular pathways of cyclic nucleotide-induced inhibition of arterial smooth muscle cell proliferation.  J Cell Physiol. 2001;  186 1-10
• 10 Beretz A, Joly M, Stoclet J C, Anton R. Inhibition of 3′,5′-AMP phosphodiesterase by biflavonoids and xanthones.  Planta Med. 1979;  36 193-5
• 11 Saponara R, Bosisio E. Inhibition of cAMP-phosphodiesterase by biflavones of Ginkgo biloba in rat adipose tissue.  J Nat Prod. 1998;  61 1386-7
• 12 Dell’Agli M, Bosisio E. Biflavones of Ginkgo biloba stimulate lipolysis in 3T3-L1 adipocytes.  Planta Med. 2002;  68 76-9
• 13 Lin C S, Lau A, Tu R, Lue T F. Expression of three isoforms of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in human penile cavernosum.  Biochem Biophys Res Commun. 2000;  268 628-35
• 14 Gobbato S, Griffini A, Lolla E, Peterlongo F. HPLC quantitative analysis of biflavones in Ginkgo biloba leaf extracts and their identification by thermospray liquid chromatography-mass spectrometry.  Fitoterapia. 1996;  67 152-8
• 15 Dell’Agli M, Galli G V, Vrhovsek U, Mattivi F, Bosisio E. In vitro inhibition of human cGMP-specific phosphodiesterase-5 by polyphenols from red grapes.  J Agric Food Chem. 2005;  53 1960-5
• 16 Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.  Anal Biochem. 1976;  72 248-54
• 17 Kincaid R L, Manganiello V C. Assay of cyclic nucleotide phosphodiesterase using radiolabeled and fluorescent substrates.  Methods Enzymol. 1988;  159 457-70